We are driven to achieve the highest and sustained efficacy of myopia management, superior visual performance, and accessibility for all children. We believe myopia management solutions should be simple to prescribe, affordable and readily implemented at scale to reduce the disproportionate burden of myopia in lower socioeconomic populations. These principles are embedded into our intellectual property and product portfolio.
nthalmic’s myopia management technology assets (S.T.O.P®, A.R.R.E.S.T®, P.A.U.S.E™) address unmet treatment needs in the eyecare market. We are now at the right stage in our journey to welcome expressions of interest from like-minded commercial partners and investors, who share our mission and values, to accelerate the development of our next-generation solutions. To learn more about our current product pipeline, explore our technologies: